CDC s latest interim guidance recommends against use of dolutegravir DTG for

By vgreene, 12 October, 2021
Exclude Patient Type Detail Header
No
Detail Type
Text
Detail Text
Non pregnant women of childbearing potential who are sexually active or have been sexually assaulted and who are not using an effective birth control method and
Pregnant women early in pregnancy since risk of an unborn infant developing a neural tube defect is during the first 28 days
Patient Type Detail Header (Long)
CDC’s <a href=https://www.cdc.gov/hiv/pdf/basics/cdc-hiv-dolutegravir-alert.pdf><u>latest interim guidance</u></a> recommends against use of dolutegravir (DTG) for: